trending Market Intelligence /marketintelligence/en/news-insights/trending/uhmzgnk5mm_l2x9anjktpg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kindred gets positive nod by independent proxy adviser for $4.1B Humana deal

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools


Kindred gets positive nod by independent proxy adviser for $4.1B Humana deal

Independent proxy advisory firm Institutional Shareholder Services Inc. recommended Kindred Healthcare Inc. shareholders vote in favor of a $4.1 billion merger deal.

Louisville, Ky.-based Humana Inc., alongside private equity firms TPG Capital Management LP and Welsh Carson Anderson & Stowe, have offered to buy the healthcare services for $9 per share.

Activist investor Brigade Capital Management, which holds a 5.8% stake in the medical-facility operator, has opposed the merger and plans to vote against it in a special meeting of shareholders March 29.

Kindred continues to expect to close the transaction in the summer of 2018.

Kindred President and CEO Benjamin Breier said the deal offered "certain cash value" to existing shareholders given the "significant operational, regulatory, reimbursement and capital structure risks" the company is facing due to high leverage and pending debt maturities.